Swiss Life Asset Management’s Insmed INSM Stock Holding History

Swiss Life Asset Management’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.94M	Buy	27,552 +9,046	+49%	+$1.1M	0.01%	541
2026 Q1	$3.03M	Buy	18,506 +4,502	+32%	+$692K	0.01%	498
2025 Q4	$2.44M	Buy	14,004 +5,288	+61%	+$965K	0.01%	536
2025 Q3	$1.26M	Buy	8,716 +3,973	+84%	+$487K	0.01%	610
2025 Q2	$477K	Buy	4,743 +2,119	+81%	+$162K	﹤0.01%	667
2025 Q1	$200K	Buy	+2,624	New	+$201K	﹤0.01%	691

Other funds holding INSM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Swiss Life Asset Management's INSM Position: Q2 2026 in Review

Swiss Life Asset Management increased its Insmed (INSM) stake by 49% in Q2 2026, buying an estimated $1.1M and bringing the position to 27,552 shares worth $2.94M. The position accounts for 0.01% of the portfolio, ranked #541.

Swiss Life Asset Management first reported a position in INSM in Q1 2025 and has held it in 6 quarters since. The position peaked at $3.03M in Q1 2026. 382 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

Swiss Life Asset Management held 27,552 shares of Insmed worth $2.94M as of Q2 2026.
Swiss Life Asset Management bought 9,046 Insmed shares in Q2 2026, an estimated $1.1M.
Insmed made up 0.01% of Swiss Life Asset Management's portfolio in Q2 2026, its #541 holding.
Swiss Life Asset Management first reported a position in Insmed in Q1 2025 and has held it in 6 quarters since.
Swiss Life Asset Management's Insmed position peaked at $3.03M in Q1 2026.
382 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Swiss Life Asset Management's 13F filing for Q2 2026, filed 29 Jul 2026.